The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Soliris (Eculizumab) Market Research Report 2025
Synopsis
The global market for Soliris (Eculizumab) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
In Asia-Pacific, Japan is the largest Soliris (Eculizumab) market with about 32% market share. China is follower, accounting for about 25% market share.The key manufacturers are Alexion etc.
This report aims to provide a comprehensive presentation of the global market for Soliris (Eculizumab), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soliris (Eculizumab).
The Soliris (Eculizumab) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Soliris (Eculizumab) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soliris (Eculizumab) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alexion
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
aHUS
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soliris (Eculizumab) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global market for Soliris (Eculizumab) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Eculizumab, sold under the trade name Soliris, is a medication used to treat paroxysmal nocturnal hemoglobinuria (PHN) and atypical hemolytic uremic syndrome (aHUS). It is a humanized monoclonal antibody functioning as a terminal complement inhibitor. In people with PNH, it reduces both the destruction of red blood cells and need for blood transfusion, but does not appear to affect the risk of death. Eculizumab was the first drug approved for each of its uses, and its approval was granted on the basis of small clinical trials.
In Asia-Pacific, Japan is the largest Soliris (Eculizumab) market with about 32% market share. China is follower, accounting for about 25% market share.The key manufacturers are Alexion etc.
This report aims to provide a comprehensive presentation of the global market for Soliris (Eculizumab), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soliris (Eculizumab).
The Soliris (Eculizumab) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Soliris (Eculizumab) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Soliris (Eculizumab) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Alexion
Segment by Type
Plasma Exchange
Plasma Infusion
Segment by Application
PNH
aHUS
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Soliris (Eculizumab) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Soliris (Eculizumab) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Plasma Exchange
1.2.3 Plasma Infusion
1.3 Market by Application
1.3.1 Global Soliris (Eculizumab) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 PNH
1.3.3 aHUS
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Soliris (Eculizumab) Market Perspective (2020-2031)
2.2 Global Soliris (Eculizumab) Growth Trends by Region
2.2.1 Global Soliris (Eculizumab) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Soliris (Eculizumab) Historic Market Size by Region (2020-2025)
2.2.3 Soliris (Eculizumab) Forecasted Market Size by Region (2026-2031)
2.3 Soliris (Eculizumab) Market Dynamics
2.3.1 Soliris (Eculizumab) Industry Trends
2.3.2 Soliris (Eculizumab) Market Drivers
2.3.3 Soliris (Eculizumab) Market Challenges
2.3.4 Soliris (Eculizumab) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Soliris (Eculizumab) Players by Revenue
3.1.1 Global Top Soliris (Eculizumab) Players by Revenue (2020-2025)
3.1.2 Global Soliris (Eculizumab) Revenue Market Share by Players (2020-2025)
3.2 Global Soliris (Eculizumab) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Soliris (Eculizumab) Revenue
3.4 Global Soliris (Eculizumab) Market Concentration Ratio
3.4.1 Global Soliris (Eculizumab) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Soliris (Eculizumab) Revenue in 2024
3.5 Global Key Players of Soliris (Eculizumab) Head office and Area Served
3.6 Global Key Players of Soliris (Eculizumab), Product and Application
3.7 Global Key Players of Soliris (Eculizumab), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Soliris (Eculizumab) Breakdown Data by Type
4.1 Global Soliris (Eculizumab) Historic Market Size by Type (2020-2025)
4.2 Global Soliris (Eculizumab) Forecasted Market Size by Type (2026-2031)
5 Soliris (Eculizumab) Breakdown Data by Application
5.1 Global Soliris (Eculizumab) Historic Market Size by Application (2020-2025)
5.2 Global Soliris (Eculizumab) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Soliris (Eculizumab) Market Size (2020-2031)
6.2 North America Soliris (Eculizumab) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Soliris (Eculizumab) Market Size by Country (2020-2025)
6.4 North America Soliris (Eculizumab) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Soliris (Eculizumab) Market Size (2020-2031)
7.2 Europe Soliris (Eculizumab) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Soliris (Eculizumab) Market Size by Country (2020-2025)
7.4 Europe Soliris (Eculizumab) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Soliris (Eculizumab) Market Size (2020-2031)
8.2 Asia-Pacific Soliris (Eculizumab) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Soliris (Eculizumab) Market Size by Region (2020-2025)
8.4 Asia-Pacific Soliris (Eculizumab) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Soliris (Eculizumab) Market Size (2020-2031)
9.2 Latin America Soliris (Eculizumab) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Soliris (Eculizumab) Market Size by Country (2020-2025)
9.4 Latin America Soliris (Eculizumab) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Soliris (Eculizumab) Market Size (2020-2031)
10.2 Middle East & Africa Soliris (Eculizumab) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Soliris (Eculizumab) Market Size by Country (2020-2025)
10.4 Middle East & Africa Soliris (Eculizumab) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Alexion
11.1.1 Alexion Company Details
11.1.2 Alexion Business Overview
11.1.3 Alexion Soliris (Eculizumab) Introduction
11.1.4 Alexion Revenue in Soliris (Eculizumab) Business (2020-2025)
11.1.5 Alexion Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Soliris (Eculizumab) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Plasma Exchange
Table 3. Key Players of Plasma Infusion
Table 4. Global Soliris (Eculizumab) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Soliris (Eculizumab) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Soliris (Eculizumab) Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Soliris (Eculizumab) Market Share by Region (2020-2025)
Table 8. Global Soliris (Eculizumab) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Soliris (Eculizumab) Market Share by Region (2026-2031)
Table 10. Soliris (Eculizumab) Market Trends
Table 11. Soliris (Eculizumab) Market Drivers
Table 12. Soliris (Eculizumab) Market Challenges
Table 13. Soliris (Eculizumab) Market Restraints
Table 14. Global Soliris (Eculizumab) Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Soliris (Eculizumab) Market Share by Players (2020-2025)
Table 16. Global Top Soliris (Eculizumab) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soliris (Eculizumab) as of 2024)
Table 17. Ranking of Global Top Soliris (Eculizumab) Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Soliris (Eculizumab) Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Soliris (Eculizumab), Headquarters and Area Served
Table 20. Global Key Players of Soliris (Eculizumab), Product and Application
Table 21. Global Key Players of Soliris (Eculizumab), Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Soliris (Eculizumab) Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Soliris (Eculizumab) Revenue Market Share by Type (2020-2025)
Table 25. Global Soliris (Eculizumab) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Soliris (Eculizumab) Revenue Market Share by Type (2026-2031)
Table 27. Global Soliris (Eculizumab) Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Soliris (Eculizumab) Revenue Market Share by Application (2020-2025)
Table 29. Global Soliris (Eculizumab) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Soliris (Eculizumab) Revenue Market Share by Application (2026-2031)
Table 31. North America Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Soliris (Eculizumab) Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Soliris (Eculizumab) Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Soliris (Eculizumab) Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Soliris (Eculizumab) Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Soliris (Eculizumab) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Soliris (Eculizumab) Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Soliris (Eculizumab) Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Soliris (Eculizumab) Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Soliris (Eculizumab) Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Soliris (Eculizumab) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Soliris (Eculizumab) Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Soliris (Eculizumab) Market Size by Country (2026-2031) & (US$ Million)
Table 46. Alexion Company Details
Table 47. Alexion Business Overview
Table 48. Alexion Soliris (Eculizumab) Product
Table 49. Alexion Revenue in Soliris (Eculizumab) Business (2020-2025) & (US$ Million)
Table 50. Alexion Recent Development
Table 51. Research Programs/Design for This Report
Table 52. Key Data Information from Secondary Sources
Table 53. Key Data Information from Primary Sources
Table 54. Authors List of This Report
List of Figures
Figure 1. Soliris (Eculizumab) Picture
Figure 2. Global Soliris (Eculizumab) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Soliris (Eculizumab) Market Share by Type: 2024 VS 2031
Figure 4. Plasma Exchange Features
Figure 5. Plasma Infusion Features
Figure 6. Global Soliris (Eculizumab) Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Soliris (Eculizumab) Market Share by Application: 2024 VS 2031
Figure 8. PNH Case Studies
Figure 9. aHUS Case Studies
Figure 10. Others Case Studies
Figure 11. Soliris (Eculizumab) Report Years Considered
Figure 12. Global Soliris (Eculizumab) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Soliris (Eculizumab) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Soliris (Eculizumab) Market Share by Region: 2024 VS 2031
Figure 15. Global Soliris (Eculizumab) Market Share by Players in 2024
Figure 16. Global Top Soliris (Eculizumab) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soliris (Eculizumab) as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Soliris (Eculizumab) Revenue in 2024
Figure 18. North America Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Soliris (Eculizumab) Market Share by Country (2020-2031)
Figure 20. United States Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Soliris (Eculizumab) Market Share by Country (2020-2031)
Figure 24. Germany Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Soliris (Eculizumab) Market Share by Region (2020-2031)
Figure 32. China Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Soliris (Eculizumab) Market Share by Country (2020-2031)
Figure 40. Mexico Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Soliris (Eculizumab) Market Share by Country (2020-2031)
Figure 44. Turkey Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Soliris (Eculizumab) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Alexion Revenue Growth Rate in Soliris (Eculizumab) Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
